- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03492372
Molecular Characterization of Spinal Tissue
August 7, 2023 updated by: A. Noelle Larson, Mayo Clinic
The researchers are trying to identify molecular mechanisms that control spine deformity and degenerative changes that can be used for therapeutic strategies.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
Discarded surgical material from spinal procedures is collected.
RNA analysis and other tests on the tissue is performed to determine markers of pathologic disease and to develop pharmacologic treatment strategies for pediatric spinal disorders.
Study Type
Observational
Enrollment (Estimated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 80 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing spinal surgery where spinal tissues (disc, cartilage, ligament, etc.) is removed as discarded tissue, waste, or surgical debris.
Description
Inclusion Criteria:
- Children and adults undergoing surgical procedures where spinal tissues are removed as a normal part of their procedure. Material from adults may be collected as a control group.
Exclusion Criteria:
- Surgeries where spinal tissues are not being removed.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Spine patients
Patients undergoing spine surgery where spinal tissue is discarded/removed will be recruited.
Tissue samples will be used to look at normal and pathologic molecular signatures.
|
This is a single visit study.
Waste tissues are collected at the time of spinal surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
RNA expression
Time Frame: Baseline
|
Measure RNA levels in spinal tissues samples (ng/mL)
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: A.Noelle Larson, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 31, 2015
Primary Completion (Estimated)
July 1, 2025
Study Completion (Estimated)
July 1, 2025
Study Registration Dates
First Submitted
January 25, 2018
First Submitted That Met QC Criteria
April 6, 2018
First Posted (Actual)
April 10, 2018
Study Record Updates
Last Update Posted (Actual)
August 8, 2023
Last Update Submitted That Met QC Criteria
August 7, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-008177
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Diseases
-
National Taiwan University HospitalCompletedSpinal Cord Injury, Degenerative Spinal Disease.Taiwan
-
Medtronic Spinal and BiologicsMedtronic Bakken Research CenterRecruitingSpinal Deformity | Spinal Degenerative Disorder | Spinal Trauma | Spinal Fusion Failure | Spinal Tumor CaseUnited States
-
RTI SurgicalCompletedSpinal Disease | Spinal Instability | Spinal Stenosis Occipito-Atlanto-Axial | Spinal Stenosis Cervical | Spinal Stenosis Cervicothoracic RegionUnited States
-
Mundipharma Korea LtdCompletedSpinal DisorderKorea, Republic of
-
Rijnstate HospitalMedical Metrics Diagnostics, IncNot yet recruitingLumbar Spinal Stenosis | Spinal InstabilityNetherlands
-
Masaryk UniversityPalacky UniversityRecruitingDegenerative Cervical Spinal Myelopathy | Cervical Spinal Cord CompressionCzechia
-
Duke UniversityRecruiting
-
Orthofix Inc.RecruitingSpinal Disorders/InjuriesSpain, United States, Germany, South Africa
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
Clinical Trials on Waste tissues are collected at the time of spinal surgery.
-
Duke UniversityUnited States Department of DefenseCompleted
-
The First Affiliated Hospital with Nanjing Medical...UnknownProliferative Diabetic Retinopathy | VEGF OverexpressionChina
-
Nantes University HospitalCompletedPatients Receiving Animal-derived Bioprosthetic Heart ValvesFrance, Canada, Italy, Spain
-
Ataturk UniversityCompletedAnesthesia, Local | Cesarean Section Complications | HypotensionTurkey
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; McMaster UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Vanderbilt University Medical CenterUMC UtrechtCompleted